Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NS101 in Healthy Volunteers and Sudden Sensorineural Hearing Loss
NCT06249919Phase 2Completed
- Sponsor
- Neuracle Science
- Start
- Feb 2024
- Primary completion
- May 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of NS101 in sudden sensorineural hearing loss (SSHL), sponsored by Neuracle Science. Started Feb 2024; status: completed.
02
Drugs
NS101
03
Conditions
sudden sensorineural hearing loss (SSHL)
Beyond the preview
Go deeper on NCT06249919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06249919.